BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28180277)

  • 1. Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
    Skowronski DM; Chambers C; De Serres G; Sabaiduc S; Winter AL; Dickinson JA; Gubbay JB; Fonseca K; Drews SJ; Charest H; Martineau C; Krajden M; Petric M; Bastien N; Li Y; Smith DJ
    J Infect Dis; 2017 Apr; 215(7):1059-1099. PubMed ID: 28180277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    Skowronski DM; Leir S; Sabaiduc S; Chambers C; Zou M; Rose C; Olsha R; Dickinson JA; Winter AL; Jassem A; Gubbay JB; Drews SJ; Charest H; Chan T; Hickman R; Bastien N; Li Y; Krajden M; De Serres G
    J Infect Dis; 2022 Apr; 225(8):1387-1398. PubMed ID: 32215564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
    Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
    Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
    McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
    JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
    Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
    Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Krajden M; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Kwindt TL; Bastien N; Li Y
    Clin Infect Dis; 2016 Jul; 63(1):21-32. PubMed ID: 27025838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
    Jiménez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Pérez E; Gallardo V; Rodriguez C; Vega T; Quiñones C; Martínez E; Vanrell JM; Giménez J; Castrillejo D; Serrano Mdel C; Ramos JM; Larrauri A;
    BMC Infect Dis; 2013 Sep; 13():441. PubMed ID: 24053661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.